U.S., Oct. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07222423) titled 'A Study of the Epidemiology and Hospital Management of Patients With PROS in France' on Oct. 27.
Brief Summary: The purpose of this study was to estimate the incidence and prevalence of a group of genetic disorders known as PIK3CA-Related Overgrowth Spectrum (PROS) in France. Additionally, the study aimed to characterize patients, disease management, and costs associated with PROS. This study used data from the French National Hospitals Database, Programme de Medicalisation des Systemes d'Information (PMSI). The study period was from January 2015 to December 2022.
Study Start Date: Jan. 15, 2024
Study Type: OBSERVATIONAL
Conditio...